Complicating intravenous immunoglobulin therapy

Annals of Pharmacotherapy

Volumn 30, Issue 10, 1996, Pages 1115-1116

  Shorr, Andrew F ^a,b   Kester, Kent E ^a,b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADULT; ARTICLE; AUTOIMMUNITY; CASE REPORT; FEMALE; HEPATITIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MENINGITIS; PRIORITY JOURNAL; SINUSITIS; ASEPTIC MENINGITIS; CHEMICALLY INDUCED DISORDER; SYNDROME; TOXIC HEPATITIS;

ADULT; FEMALE; HEPATITIS, TOXIC; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MENINGITIS, ASEPTIC; SYNDROME;

EID: 0030255253     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603001010     Document Type: Article

References (6)

1. Mobini N, Sarela A, Ahmed AR. Intravenous immunoglobulin in the therapy of autoimmune and systemic inflammatory disorders. Ann Allergy Asthma Immunol 1995;74:119-28.
2. Duhem C, Dicato MA, Ries F. Side effects of intravenous immune globulins. Clin Exp Immunol 1994;97(suppl 1):79-83.
3. Sekul EA, Cupler EJ, Dalakas MC. Aseptic meningitis associated with high dose intravenous immunoglobulin therapy: frequency and risk factors. Ann Intern Med 1994;121:259-62.
4. Scribner CL, Kapit RM, Phillips ET, Rickles NM. Aseptic meningitis and intravenous immunoglobulin therapy. Ann Intern Med 1994;121: 305-6.
5. Schneider L, Geha R. Outbreak of hepatitis C associated with intravenous immunoglobulin administration - United States, October 1993-June 1994. MMWR Morb Mortal Wkly Rep 1994;43:505-9.
6. Bjorkander J, Cunningham-Rundles C, Lundin P, Olsson R, Soderstrom R, Hanson LA. Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. Am J Med 1988;84:107-11.